Concord Biotech (BOM:543960) Gross-Profit-to-Asset % : 52.14% (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Concord Biotech Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Concord Biotech's annualized Gross Profit for the quarter that ended in Mar. 2024 was ₹8,477 Mil. Concord Biotech's average Total Assets over the quarter that ended in Mar. 2024 was ₹16,259 Mil. Therefore, Concord Biotech's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 was 52.14%.

Concord Biotech Gross-Profit-to-Asset % Historical Data

The historical data trend for Concord Biotech's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Concord Biotech Gross-Profit-to-Asset % Chart

Concord Biotech Annual Data

Trend

Mar20

Mar21

Mar22

Mar23

Mar24

Gross-Profit-to-Asset %

38.35

45.57

42.52

47.61

49.01

Concord Biotech Semi-Annual Data
	Mar20	Mar21	Mar22	Sep22	Mar23	Sep23	Mar24
Gross-Profit-to-Asset %	Get a 7-Day Free Trial			-	40.49	48.59	47.49	52.14

Competitive Comparison of Concord Biotech's Gross-Profit-to-Asset %

For the Biotechnology subindustry, Concord Biotech's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Concord Biotech's Gross-Profit-to-Asset % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Concord Biotech's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Concord Biotech's Gross-Profit-to-Asset % falls into.

Concord Biotech Gross-Profit-to-Asset % Calculation

Concord Biotech's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Mar. 2024 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (A: Mar. 2024 )	/	( (Total Assets (A: Mar. 2023 )	+	Total Assets (A: Mar. 2024 ))	/ count )
	=	7877.411	/	( (15139.84	+	17007.085)	/ 2 )
	=	7877.411	/	16073.4625
	=	49.01 %

Concord Biotech's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (Q: Mar. 2024 )	/	( (Total Assets (Q: Sep. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
	=	8476.698	/	( (15510.255	+	17007.085)	/ 2 )
	=	8476.698	/	16258.67
	=	52.14 %

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is two times the semi-annual (Mar. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

Concord Biotech Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Concord Biotech's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

Concord Biotech (BOM:543960) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Concord Biotech Ltd (BOM:543960) » Definitions » Gross-Profit-to-Asset %

Comparable Companies

Traded in Other Exchanges

CONCORDBIO:India

Address

Iscon Cross Road, S.G. Highway, 16th floor, B-Wing, Mondeal Heights, Ahmedabad, GJ, IND, 380015

Website

https://www.concordbiotech.com

Concord Biotech Ltd is a Research & development-driven biopharma Company that manufactures Active Pharmaceutical Ingredients (API) through fermentation & semi-synthetic process and finished formulations.

Concord Biotech (BOM:543960) Headlines

No Headlines